Technology | Breast Imaging | May 20, 2016

FDA Approves Standalone 3-D Screening With Siemens Tomosynthesis Platform

Mammomat Inspiration with Tomosynthesis Option showed superior results to 2-D alone in reader study

Siemens, FDA, mammography, 3-D screening, tomosynthesis, Mammomat Inspiration

May 20, 2016 — Siemens Healthineers announced that the U.S. Food and Drug Administration (FDA) has approved the use of 3-D-only screening mammography utilizing the company’s Mammomat Inspiration with Tomosynthesis Option digital mammography system.

Siemens said the system is the first and only 3-D digital breast tomosynthesis (DBT) platform to be approved by the FDA as a stand-alone screening and diagnostic system; all other mammography systems on the market require a combination of 2-D and 3-D examinations.

FDA approval of the 3-D-only application follows a pivotal reader study in which participating radiologists demonstrated their ability to increase cancer detection at a lower radiation dose than combined 2-D and DBT. In the study, radiologists decreased average recall rates by an average of 19 percent without the need for a 2-D image.

Siemens’ Tomosynthesis Only Option is available on the company’s Mammomat Inspiration and Mammomat Inspiration Prime Edition digital mammography systems.

For more information: www.healthcare.siemens.com

Related Content

September 28, 2021 — A computer program trained to see patterns among thousands of breast ultrasound images can aid physicians in accurately diagnosing breast cancer, a new study shows.

Breast ultrasound images show cancer (at left, as dark spot in center and, at right, in red, as highlighted by a computer). Image courtesy of Nature Communications

News | Breast Imaging | September 28, 2021
September 28, 2021 — A computer program trained to see patterns among thousands of...
Volpara Health, a global health technology software leader providing an integrated platform for the delivery of personalized breast and lung care, further expanded its footprint in the US lung screening market with a strategic relationship with Seattle-based lung AI company RevealDx.

Getty Images

News | Lung Imaging | September 27, 2021
September 27, 2021 — Volpara Health, a global health technology software leader providing an integrated platform for
This study shows that thanks to deep learning analysis applied to digitized pathology slides, artificial intelligence can classify patients with localized breast cancer between high risk and low risk of metastatic relapse in the next five years.

Getty Images

News | Artificial Intelligence | September 22, 2021
September 22, 2021 — The RACE AI study conducted by Gustave...
News | Breast Imaging | September 20, 2021
September 20, 2021 — ImageCare Centers is unveiling its new “PINK Better Mammo” service with the addition of...
This is an example of 3-D ultrasound imaging on a breast, designed to help increase efficiency and diagnostic accuracy in any practice. Image courtesy of Hologic.

This is an example of TriVu ultrasound imaging on a breast, designed to help increase efficiency and diagnostic accuracy in any practice. Image courtesy of Hologic.

Feature | Breast Imaging | September 15, 2021 | By Jennifer Meade
The...
While the Mammography Quality Standards Act (MQSA) and the introduction of EQUIP (Enhancing Quality Using the Inspection Program) have been successful in standardizing and enhancing mammographic imaging quality, inadequate breast positioning can dramatically impact the ability of radiologists and technicians to quickly and accurately detect breast cancer and potentially malignant lesions in their patients

Getty Images

Feature | Mammography | September 15, 2021 | By Christopher Austin, M.D. and Randy D. Hicks, M.D., MBA
Plan to attend RSNA21 at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | September 13, 2021
September 13, 2021 — The Radiological Society of North America (RSNA) today announced highlights of the Technical Exh
According to ARRS’ American Journal of Roentgenology (AJR), immediately reading screening mammograms during the coronavirus disease (COVID-19) pandemic promises a new and improved paradigm—reducing care disparities, while increasing the speed of diagnostic workup.

Flow Chart of Patient Selection

News | Breast Imaging | September 09, 2021
September 9, 202